Variant report
Variant | esv3402650 |
---|---|
Chromosome Location | chr17:20782198-20782472 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:20780706..20782458-chr17:20785204..20786797,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DHRS7B-8 | chr17:20782018-20783423 | ucscGeneNc_uc002gyj_2 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75052836 | chr17:20782212-20782213 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs78731992 | chr17:20782218-20782219 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs77341698 | chr17:20782222-20782223 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs76638430 | chr17:20782226-20782227 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs75447336 | chr17:20782230-20782231 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs577535707 | chr17:20782240-20782241 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs191217052 | chr17:20782243-20782244 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs563271976 | chr17:20782245-20782246 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs199769084 | chr17:20782249-20782250 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs113541720 | chr17:20782271-20782272 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs376014712 | chr17:20782297-20782298 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs76518909 | chr17:20782298-20782299 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs368881860 | chr17:20782308-20782309 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs561028141 | chr17:20782323-20782324 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs371577519 | chr17:20782325-20782326 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs112003386 | chr17:20782327-20782328 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs546550728 | chr17:20782328-20782329 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs371634220 | chr17:20782333-20782334 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs369124466 | chr17:20782337-20782338 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs199648829 | chr17:20782340-20782341 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs9905192 | chr17:20782357-20782358 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs371963151 | chr17:20782369-20782370 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs375268765 | chr17:20782371-20782372 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs372159263 | chr17:20782374-20782375 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs549689259 | chr17:20782375-20782376 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs375519203 | chr17:20782377-20782378 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs201890943 | chr17:20782383-20782384 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs369439706 | chr17:20782407-20782408 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs9899381 | chr17:20782413-20782414 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs182089794 | chr17:20782449-20782450 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs569055625 | chr17:20782451-20782452 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs143787545 | chr17:20782454-20782455 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17142309 | CNVD |
Autism | 20808228 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:20780600-20784000 | Weak transcription | HepG2 | liver |
2 | chr17:20780800-20782200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr17:20780800-20784000 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr17:20780800-20790000 | Weak transcription | K562 | blood |
5 | chr17:20780800-20791000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr17:20780800-20801600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr17:20782200-20782600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |